Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD | |
Liang Jun[1]; Liu Ying[2]; Liu Jinguang[3]; Li Zhe[4]; Fan Qiangyuan[5]; Jiang Zifei[6]; Yan Fei[7]; Wang Zhi[8]; Huang Peiwen[9]; Feng Nianping[10] | |
刊名 | Journal of nanobiotechnology |
2018 | |
卷号 | 16页码:64 |
关键词 | Chitosan-functioned lipid-polymer hybrid nanoparticle Lipid-lowering effect Non-alcoholic fatty liver disease Oral bioavailability Silymarin |
ISSN号 | 1477-3155 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2172750 |
专题 | 上海大学 |
作者单位 | School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. |
推荐引用方式 GB/T 7714 | Liang Jun[1],Liu Ying[2],Liu Jinguang[3],et al. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD[J]. Journal of nanobiotechnology,2018,16:64. |
APA | Liang Jun[1].,Liu Ying[2].,Liu Jinguang[3].,Li Zhe[4].,Fan Qiangyuan[5].,...&Feng Nianping[10].(2018).Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.Journal of nanobiotechnology,16,64. |
MLA | Liang Jun[1],et al."Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD".Journal of nanobiotechnology 16(2018):64. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论